SENSEX: 72,400 ▲ 0.5% NIFTY: 21,800 ▲ 0.4% GOLD: 62,500 ▼ 0.2%

Search Results for: NSE%3ATATVA

Tatva Chintan Pharma Chem Limited (TATVA) Q1 FY23 Earnings Concall Transcript

July 25, 2022

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Q1 FY23 Earnings Concall dated Jul. 25, 2022 Corporate Participants: Chintan Nitinkumar Shah — Managing Director Ashok Bothra — Chief Financial Officer Analysts: Nirali Gopani — Unique Asset Management — Analyst Isha Agarwal — VT Capital — Analyst Rohan Kamath — — Analyst Sanjesh Jain — ICICI Securities — […]